Contraception and Family Planning Practice Questions

Q: Which contraceptive method should be avoided in patients with epilepsy?

Oral contraceptives. **Explanation:** The primary concern in managing contraception for patients with epilepsy is the **pharmacokinetic interaction** between antiepileptic drugs (AEDs) and hormonal contraceptives. **1. Why Oral Contraceptives (OCPs) are avoided:** Most traditional AEDs (e.g., Phenytoin, Carbamazepine, Phenobarbital, Primidone) are **potent hepatic enzyme inducers** (Cytochrome P450 system). These enzymes accelerate the metabolism of estrogen and progesterone in OCPs, significantly reducing their serum concentrations. This leads to a high risk of **contraceptive failure** and unintended pregnancy. Conversely, OCPs can lower the serum levels of certain AEDs like **Lamotrigine**, potentially triggering breakthrough seizures. **2. Analysis of Incorrect Options:** * **Condoms (Barrier Methods):** These do not involve systemic hormones or hepatic metabolism; therefore, there is no drug interaction. * **Intrauterine Contraceptive Devices (IUCDs):** Copper T or Levonorgestrel-releasing IUS (Mirena) act locally. They are considered the **gold standard** for women on enzyme-inducing AEDs because their efficacy is not affected by liver enzymes. * **Post-coital pills:** While emergency contraception (EC) can be used, it is not "avoided" in the same sense as maintenance OCPs. However, a double dose (3mg Levonorgestrel) is often recommended if the patient is on enzyme-inducers. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** The Copper IUCD or LNG-IUS are the most reliable methods for epileptic patients. * **DMPA (Injectable):** Can be used, but the injection interval is sometimes shortened to 10 weeks instead of 12. * **Non-inducing AEDs:** Valproate, Levetiracetam, and Gabapentin do not significantly interact with OCPs, but OCPs are still generally avoided as a first-line precaution in epilepsy management.

Q: What is the most ideal site for sterilization by tubectomy?

Isthmus. The **isthmus** is the most ideal site for tubal sterilization (tubectomy) because it is the narrowest and least vascular part of the Fallopian tube. ### Why Isthmus is the Correct Answer: 1. **Anatomical Advantage:** The isthmus has a thick muscular wall and a narrow lumen. This makes it technically easier to ligate and excise (as in the Pomeroy technique) or to apply mechanical devices like clips or rings. 2. **Vascularity:** It is relatively less vascular compared to the ampulla, minimizing the risk of intraoperative bleeding and hematoma formation. 3. **Reversibility:** Because the isthmus is narrow, a tubectomy here destroys the least amount of tubal tissue. If a patient requests tubal re-anastomosis (reversal) later, the isthmic-isthmic repair offers the highest success rates due to the matching luminal diameters. ### Why Other Options are Incorrect: * **Ampulla:** This is the widest and most vascular part of the tube. Sterilization here carries a higher risk of bleeding and requires destroying a larger segment of the tube, making future reversal difficult. * **Fimbriated extremity:** Removing the fimbria (fimbriectomy) is highly effective but makes the procedure virtually irreversible. * **Interstitial portion:** This is the segment that traverses the uterine wall. Surgery here is technically difficult, carries a high risk of uterine bleeding, and increases the risk of cornual pregnancy if failure occurs. ### Clinical Pearls for NEET-PG: * **Pomeroy’s Method:** The most common technique used worldwide; it involves ligating a loop of the isthmus with absorbable suture. * **Failure Rate:** The Pearl Index for tubectomy is approximately **0.5 per 100 woman-years**. * **Madlener Technique:** Avoided today due to high failure rates (re-canalization). * **Irving and Uchida Techniques:** Have the lowest failure rates but are surgically more complex.

Q: Which of the following neoplasms has been associated with the use of oral contraceptives?

Hepatic adenoma. **Explanation:** The correct answer is **Hepatic Adenoma**. Combined Oral Contraceptive Pills (COCPs) contain synthetic estrogen and progesterone. Estrogen, in particular, has a trophic effect on hepatocytes and the hepatic vasculature. Long-term use of COCPs is a well-established risk factor for the development of **Hepatic Adenoma** (a benign but potentially serious liver tumor). These tumors are highly vascular and carry a risk of spontaneous rupture and life-threatening intraperitoneal hemorrhage, especially during pregnancy or continued pill use. **Analysis of Incorrect Options:** * **Ovarian Cancer:** COCPs are actually **protective** against epithelial ovarian cancer. The suppression of "incessant ovulation" reduces the risk by approximately 50% after 5 years of use, and this protection persists for decades after discontinuation. * **Endometrial Cancer:** COCPs are **protective** against endometrial cancer. The progestogen component counteracts the proliferative effect of estrogen on the endometrium, reducing the risk by about 50%. * **Breast Cancer:** While there is a slight, transient increase in the relative risk of breast cancer diagnosis during current use (which returns to baseline 10 years after stopping), the association is less definitive and less "classically" linked in exam scenarios compared to the specific association with hepatic adenoma. **High-Yield NEET-PG Pearls:** * **Cancers Decreased by COCPs:** Ovarian, Endometrial, and Colorectal cancer. * **Cancers Increased by COCPs:** Cervical cancer (risk increases with >5 years of use) and Hepatic Adenoma. * **Management of Hepatic Adenoma:** Small adenomas (<5 cm) may regress upon discontinuation of COCPs; larger ones may require surgical resection due to the risk of rupture or malignant transformation to Hepatocellular Carcinoma (HCC).

Q: What is the recommended pressure range employed during suction evacuation in MTP?

400-600 mm Hg. ### Explanation **Suction Evacuation (Vacuum Aspiration)** is the gold standard surgical method for Medical Termination of Pregnancy (MTP) in the first trimester (up to 12 weeks). **1. Why 400-600 mm Hg is Correct:** To effectively detach and aspirate the products of conception (decidua and chorionic tissue) from the uterine wall, a negative pressure of **400–600 mm Hg** (or 60–80 kPa) is required. This range provides sufficient suction to empty the uterus quickly while minimizing the risk of trauma to the myometrium. **2. Analysis of Incorrect Options:** * **A (200-400 mm Hg):** This pressure is generally **insufficient** to dislodge the gestational sac and placental tissue, leading to incomplete evacuation and increased procedure time. * **C & D (600-1000 mm Hg):** Pressures exceeding 600 mm Hg are **excessive**. High negative pressure increases the risk of uterine perforation, Asherman syndrome (due to over-denudation of the basal layer of the endometrium), and cervical injury. **3. Clinical Pearls for NEET-PG:** * **Cannula Size Rule:** The size of the Karman cannula (in mm) should correspond to the weeks of gestation (e.g., an 8 mm cannula for 8 weeks of pregnancy). * **Manual Vacuum Aspiration (MVA):** Uses a handheld syringe (60cc) that creates a constant vacuum of approximately **600 mm Hg**. * **Signs of Completion:** The procedure is complete when "gritty" sensations are felt against the cannula, bubbles appear in the tube, and the uterus contracts around the cannula. * **MTP Act Update:** Remember that under the MTP (Amendment) Act 2021, the upper gestation limit for termination has been increased to **24 weeks** for specific categories of women.

Q: What is the most preferable contraceptive device for a female with Rheumatic Heart Disease who has completed her family?

Tubal ligation. **Explanation:** The primary concern in managing contraception for a patient with **Rheumatic Heart Disease (RHD)** is preventing unintended pregnancy, which poses a high risk of cardiac decompensation due to the physiological hemodynamic changes of pregnancy. **Why Tubal Ligation is Correct:** For a woman who has **completed her family**, permanent sterilization via **Tubal Ligation** is the most preferable method. It offers the highest efficacy (lowest failure rate) without the hormonal risks or infection concerns associated with other methods. In RHD patients, it is ideally performed during a stable cardiac period. It provides a "one-time" solution to the high-risk threat of future pregnancies. **Analysis of Incorrect Options:** * **IUCD (Option A):** Generally avoided in RHD patients due to the risk of **Pelvic Inflammatory Disease (PID)** and subsequent **Subacute Bacterial Endocarditis (SABE)**. Additionally, the vasovagal response during insertion can trigger cardiac arrhythmias in susceptible patients. * **Norplant (Option C):** While highly effective, progestin-only implants are usually reserved for those spacing pregnancies. For someone who has completed their family, permanent methods are superior. * **Barrier Method (Option D):** These have a high **user-failure rate**. In RHD, a contraceptive failure leading to pregnancy can be life-threatening; therefore, low-efficacy methods are not preferred. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Eligibility Criteria:** For RHD, sterilization is Category 2 (benefits outweigh risks), but IUCD is often Category 3/4 if there is a high risk of endocarditis. * **Prophylaxis:** If an IUCD must be used or surgery performed, **antibiotic prophylaxis** is mandatory to prevent SABE. * **OCPs:** Combined Oral Contraceptive Pills are **contraindicated** in RHD with complications (like atrial fibrillation or valve replacement) due to the increased risk of thromboembolism.

Q: Which of the following is NOT an absolute contraindication for IUCD users?

HIV infection. The correct answer is **C. HIV infection**. ### **Explanation** According to the **WHO Medical Eligibility Criteria (MEC)** for contraceptive use, HIV infection is categorized as **MEC Category 2** (benefits generally outweigh risks) for both initiation and continuation of an Intrauterine Contraceptive Device (IUCD). It is **not** an absolute contraindication. Women with HIV, including those on Antiretroviral Therapy (ART) who are clinically well, can safely use IUCDs. The risk of pelvic infection is not significantly higher in these patients compared to HIV-negative women, provided they do not have an active AIDS-defining illness (MEC 3 for initiation). ### **Why other options are wrong:** * **Undiagnosed vaginal bleeding (MEC 4):** This is an absolute contraindication because the bleeding could be due to an underlying malignancy (e.g., cervical or endometrial cancer) or pregnancy complications, which must be ruled out before insertion. * **Suspected pregnancy (MEC 4):** Insertion of an IUCD during pregnancy can lead to septic abortion, miscarriage, or preterm labor. Pregnancy must always be excluded. * **Pelvic Inflammatory Disease (PID) (MEC 4):** Current or active PID is an absolute contraindication for initiation. Inserting an IUCD during an active infection can exacerbate the condition and lead to tubal damage or infertility. ### **High-Yield Clinical Pearls for NEET-PG:** * **MEC Category 4 (Absolute Contraindications):** Undiagnosed vaginal bleeding, current PID, suspected pregnancy, copper allergy (for Cu-T), and distorted uterine cavity (fibroids). * **IUCD & HIV:** If a woman develops AIDS while using an IUCD, she can continue using it (MEC 2), but initiation in a patient with AIDS who is not on ART is MEC 3. * **Ideal Candidate:** A parous woman in a stable monogamous relationship with no history of PID. * **Most common side effect:** Bleeding (menorrhagia); **Most common reason for removal:** Pain and bleeding.

Question 1

Intermenstrual bleeding is a frequent side effect seen with which of the following?

Accepted Answer

Combined OCPs during early months of use.

Answer

Progestin-only pills during early months of use.

Answer

Combined OCPs throughout use.

Answer

Progestin-only pills where AUB never occurs.

Question 2

What is the drug of choice for medical termination of pregnancy in a patient who is second gravida with asthma at 16 weeks gestation?

Accepted Answer

Hypertonic saline

Answer

Prostaglandin

Answer

Ethacridine lactate

Answer

Intra-amniotic dexamethasone

Question 3

Progestogen-only pills (POPs) carry a risk of:

Accepted Answer

Ectopic pregnancy

Answer

Hypertension

Answer

Embolism

Answer

Irregular bleeding

Question 4

Which contraceptive method should be avoided in patients with epilepsy?

Accepted Answer

Oral contraceptives

Answer

Condoms

Answer

Intrauterine contraceptive devices

Answer

Post-coital pills

Question 5

What is the most ideal site for sterilization by tubectomy?

Accepted Answer

Isthmus

Answer

Ampulla

Answer

Fimbriated extremity

Answer

Interstitial portion

Question 6

Which of the following neoplasms has been associated with the use of oral contraceptives?

Accepted Answer

Hepatic adenoma

Answer

Breast cancer

Answer

Ovarian cancer

Answer

Endometrial cancer

Question 7

What is the recommended pressure range employed during suction evacuation in MTP?

Accepted Answer

400-600 mm Hg

Answer

200-400 mm Hg

Answer

600-800 mm Hg

Answer

800-1000 mm Hg

Question 8

What is the most preferable contraceptive device for a female with Rheumatic Heart Disease who has completed her family?

Accepted Answer

Tubal ligation

Answer

Intrauterine contraceptive device (IUCD)

Answer

Norplant

Answer

Barrier method

Question 9

All of the following are features of post-tubal ligation syndrome except?

Accepted Answer

All the above

Answer

Abnormal menstrual bleeding

Answer

Dysmenorrhea

Answer

Dyspareunia

Question 10

Which of the following is NOT an absolute contraindication for IUCD users?

Accepted Answer

HIV infection

Answer

Undiagnosed vaginal bleeding

Answer

Suspected pregnancy

Answer

Pelvic inflammatory disease

Contraception and Family Planning — MCQs

Contraception and Family Planning — MCQs

On this page

Practice by Chapter

Want unlimited practice?